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Abstract 
Background: Bipolar disorder (BD) is a chronic disorder with a high relapse rate, significant general disability and 
burden and with a psychosocial impairment that often persists despite pharmacotherapy. This indicates the need for 
effective and affordable adjunctive psychosocial interventions, tailored to the individual patient. Several psychothera-
peutic techniques have tried to fill this gap, but which intervention is suitable for each patient remains unknown and 
it depends on the phase of the illness.
Methods: The papers were located with searches in PubMed/MEDLINE through May 1st 2015 with a combination of 
key words. The review followed the recommendations of the Preferred Items for Reporting of Systematic Reviews and 
Meta-Analyses statement.
Results: The search returned 7,332 papers; after the deletion of duplicates, 6,124 remained and eventually 78 were 
included for the analysis. The literature supports the usefulness only of psychoeducation for the relapse prevention 
of mood episodes and only in a selected subgroup of patients at an early stage of the disease who have very good, 
if not complete remission, of the acute episode. Cognitive-behavioural therapy and interpersonal and social rhythms 
therapy could have some beneficial effect during the acute phase, but more data are needed. Mindfulness interven-
tions could only decrease anxiety, while interventions to improve neurocognition seem to be rather ineffective. Family 
intervention seems to have benefits mainly for caregivers, but it is uncertain whether they have an effect on patient 
outcomes.
Conclusion: The current review suggests that the literature supports the usefulness only of specific psychosocial 
interventions targeting specific aspects of BD in selected subgroups of patients.
© 2015 Miziou et al. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Our contemporary understanding of bipolar disor-
der (BD) suggests that there is an unfavorable outcome 
in a significant proportion of patients [1, 2]. In spite of 
recent advances in pharmacological treatment, many 
BD patients will eventually develop chronicity with sig-
nificant general disability and burden. The burden will 
be significant also for their families and the society as a 
whole [3, 4]. Today, we also know that unfortunately, 
symptomatic remission is not identical and does not 
imply functional recovery [5–7].
Since pharmacological treatment often fails to address 
all the patients’ needs, there is a growing need for the 
development and implementation of effective and afforda-
ble interventions, tailored to the individual patient [8]. The 
early successful treatment, with full recovery if possible, as 
well as the management of subsyndromal symptoms and 
of psychosocial stress and poor adherence are factors pre-
dicting earlier relapse and poor overall outcome [9, 10].
In this frame, there are several specific adjunctive psy-
chotherapies which have been developed with the aim of 
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filling the above gaps and eventually improve the illness 
outcome [11], but it is still unclear whether they truly 
work and which patients are eligible and when [12–19].
The current study is a systematic review of the efficacy 
of available psychosocial interventions for the treatment 
of adult patients with BD.
Methods
Reports investigating psychotherapy and psychosocial 
interventions in BD patient samples were located with 
searches in Pubmed/MEDLINE through May 1, 2015. 
Only reports in English language were included.
The Pubmed database was searched using the search 
terms ‘bipolar’ and ‘psychotherapy’ or ‘cognitive-behav-
ioral’ or ‘CBT’ or ‘psychoeducation’ or ‘interpersonal and 
social rhythm therapy’ or ‘IPSRT’ or ‘family interven-
tion’ or ‘family therapy’ or ‘group therapy’ or ‘intensive 
psychosocial intervention’ or ‘cognitive remediation’ or 
‘functional remediation’ or ‘Mindfulness’.
The following rules were applied for the selection of 
papers:
1. Papers in English language.
2. Randomized controlled trials.
This review followed the recommendations of the Pre-
ferred Items for Reporting of Systematic Reviews and 
Meta-Analyses (PRISMA) statement [20].
Results
The search returned 7,332 papers, and after the dele-
tion of duplicates 6,124 remained for further assess-
ment. After assessing these papers on the basis of title 
and abstract, the remaining papers were (Figure 1). The 
number of paper reported for each intervention includes 
RCTs, post hoc analyses and meta-analyses together.
Cognitive‑behavioural therapy (CBT)
The efficacy of CBT in BD was investigated in 14 studies 
which utilized CBT as adjunct treatment to pharmaco-
therapy or treatment as usual (TAU). They utilized some 
kind of control intervention which should not be consid-
ered as an adequate placebo. It is also interesting that the 
oldest study was conducted in 2003.
This first study lasted 12  months and concerned 103 
BD-I patients during the acute depressive phase and ran-
domized them to 14 sessions of CBT or a control inter-
vention. There was not any placebo condition. These 
authors reported that at end point fewer patients in the 
CBT group relapsed in comparison to controls (44 vs. 
75%; HR =  0.40, P =  0.004), had shorter episode dura-
tion, less admissions and mood symptoms, and higher 
social functioning [21]. It was disappointing that the 
extension of this study (18 months follow-up) was nega-
tive concerning the relapse rate [22].
A second trial included 52 BD patients and was also 
negative concerning the long-term efficacy after com-
paring CBT plus additional emotive techniques vs. TAU 
[23]. On the other hand, the comparison of CBT plus 
psychoeducation vs. TAU in 40 BD patients reported a 
beneficial effect even after 5 years in terms of symptoms 
and social–occupational functioning. However, that 
study did not report the rate of recurrences and the time 
to recurrence [24]. A study in 79 BD patients (52 BD-I 
and 27 BD-II) compared CBT plus psychoeducation vs. 
psychoeducation alone and reported that the combined 
treatment group had 50% fewer depressed days per 
month, while at the same time the psychoeducation alone 
group had more antidepressant use [25]. Another study 
on 41 BD patients randomized to CBT vs. TAU reported 
Figure 1 The PRISMA flowchart.
Page 3 of 11Miziou et al. Ann Gen Psychiatry  (2015) 14:19 
similar results and an improvement in symptoms, fre-
quency and duration of episodes [26].
An 18-month study compared CBT vs. TAU in 253 BD 
patients and reported that at end point, there were no 
differences between groups with more than half of the 
patients having a recurrence. It is interesting that a post 
hoc analysis suggested that CBT was significantly more 
effective than TAU in those patients with fewer than 12 
previous episodes, but less effective in those with more 
episodes [13]. Similar negative results were reported 
concerning the number of episodes and time to relapse 
by another 12-month study of CBT vs. TAU in 50 BD 
patients in remission [17]. Again, negative findings con-
cerning the relapse rate were reported by a 2-year study 
on 76 BD patients randomized to receive 20 sessions of 
CBT vs. support therapy [15]. Finally, the use of com-
bined CBT and pharmacotherapy in 40 patients with 
refractory bipolar disorder suggested that the combina-
tion group had less hospitalization events in comparison 
to the group in the 12-month evaluation (P = 0.015) and 
lower depression and anxiety in the 6-month (P = 0.006; 
P = 0.019), 12-month (P = 0.001; P < 0.001) and 5-year 
(P  <  0.001, P  <  0.001) evaluation time points. However 
it is interesting that after the 5-year follow-up, 88.9% of 
patients in the control group and 20% of patients in the 
combination group showed persistent affective symp-
toms and difficulties in social–occupational functioning 
[27].
The use of CBT in BD comorbid with social anxiety 
disorder is of doubtful efficacy [28], while there are some 
preliminary data on the efficacy of an Internet-based 
CBT intervention [29] as well as recovery-focused add-
on CBT [30] and CBT for insomnia [31] in comparison 
to TAU.
The review of the available data so far give limited sup-
port for the usefulness of CBT during the acute phase of 
bipolar depression as adjunctive treatment in patients 
with BD, but definitely not for the maintenance phase. 
During the maintenance phase, booster sessions might 
be necessary, but the data are generally overall nega-
tive. Probably, patients at earlier stages of the illness 
might benefit more from CBT. Unfortunately the type of 
patients who are more likely to benefit from CBT consti-
tutes a minority in usual clinical practice.
Psychoeducation
The basic concept behind psychoeducation for BD con-
cerns the training of patients regarding the overall aware-
ness of the disorder, treatment adherence, avoiding of 
substance abuse and early detection of new episodes. The 
efficacy of psychoeducation in BD was investigated in 30 
studies, all of which utilized psychoeducation as adjunct 
treatment to pharmacotherapy or TAU. All these studies 
utilize some kind of control intervention which should 
not be considered as an adequate placebo. It is also inter-
esting that the oldest study was conducted in 1991.
The earliest psychoeducational study was open and 
uncontrolled and reported that giving information about 
lithium improved the overall attitude towards treatment 
[32, 33]. A similar small study was conducted a few years 
later and reported similar results [34]. However, the first 
study on the wide teaching of patients to recognize and 
identify the components of their disease with emphasis 
on early symptoms of relapse and recurrence and to seek 
professional help as early as possible had not been con-
ducted until 1999. It included 69 patients for 18 months 
and compared psychoeducation (limited number of 
sessions; 7–12) vs. TAU. It reported a significant pro-
longation of the time to first manic relapse (P =  0.008) 
and significant reductions in the number of manic 
relapses over 18 months (30 vs. 52%; P = 0.013) as well 
as improved overall social functioning. Psychoeducation 
had no effect on depressive relapses [35].
In a more systematic way, the efficacy of the adjunc-
tive group psychoeducation was tested by the Barcelona 
group. Their trial included 120 euthymic BD patients 
who were randomly assigned to 21 sessions of group psy-
choeducation vs. non-specific group meetings. The study 
included a follow-up with a duration of 2 and 5 years. The 
results suggested that psychoeducation exerted a ben-
eficial effect on the rate of and the time to recurrence as 
well as concerning hospitalizations per patient. At the 
end of the 2-year follow-up, 23 subjects (92%) in the con-
trol group fulfilled the criteria for recurrence versus 15 
patients (60%) in the psychoeducation group (P < 0.01). 
This beneficial effect was high and was not reduced 
after 5  years (any episode 0.79 vs. 0.87; mania 0.40 vs. 
0.57; hypomania 0.27 vs. 0.42 and mixed episodes 0.34 
vs. 0.61), except for depressive episodes (0.91 vs. 0.80) 
[36–38].
The literature suggests that psychoeducation should be 
broad and that enhanced relapse prevention alone does 
not seem to work. This was the conclusion from another 
study with a different design. That study reported that 
only occupational functioning, but not time to recur-
rence, improved with an intervention consisting of 
training community mental health teams to deliver 
enhanced relapse prevention [39]. Additionally, a study 
with a 12-month follow-up and with a similar design to 
the first study of the Barcelona group, but with 16 ses-
sions, reported no differences between groups in mood 
symptoms, psychosocial functioning and quality of life. 
It did find, however, that there was a difference in the 
subjectively perceived overall clinical improvement by 
subjects who received psychoeducation. The authors sug-
gested that characteristics of the sample could explain 
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this discrepancy, as patients with a more advanced stage 
of disease might have a worse response to psychoeduca-
tion [16]. In accordance with the above, a post hoc analy-
sis of the original Barcelona data revealed that patients 
with more than seven episodes did not show significant 
improvement with group psychoeducation in time to 
recurrence, and those with more than 14 episodes did 
not benefit from the treatment in terms of time spent ill 
[40]. A 2-year follow-up in 108 BD patients investigated 
psychoeducation plus pharmacotherapy vs. pharmaco-
therapy alone. Psychoeducation concerned eight, 50-min 
sessions of psychological education, followed by monthly 
telephone follow-up care and psychological support. 
The results suggested that psychoeducation improved 
medication compliance (P  =  0.008) and quality of life 
(P  <  0.001) and had fewer hospitalizations (P  <  0.001) 
[41]. Another study randomized 80 BD patients to either 
the psychoeducation or the control group and reported 
that the psychoeducation group scored significantly 
higher on functioning levels (emotional functioning, 
intellectual functioning, feelings of stigmatization, social 
withdrawal, household relations, relations with friends, 
participating in social activities, daily activities and rec-
reational activities, taking initiative and self-sufficiency, 
and occupation) (P  <  0.05) compared with the control 
group after psychoeducation [42].
A prospective 5-year follow-up of 120 BD patients 
suggested that group psychoeducation might be more 
cost-effective [43]. In support of the cost-effectiveness 
of psychoeducation was one trial in 204 BD patients 
which compared 20 sessions of CBT vs. 6 sessions of 
group psychoeducation and reported that overall the 
outcome was similar in the two groups in terms of 
reduction of symptoms and likelihood of relapse, but 
psychoeducation was associated with a decrease of 
costs ($180 per subject vs. $1,200 per subject for CBT) 
[44] Currently, there are some proposals of online psy-
choeducation programmes, but results are still incon-
clusive or pending [45, 46].
More complex multimodal approaches and multicom-
ponent care packages have been developed and usually 
psychoeducation is a core element. One of these packages 
also included CBT and elements of dialectical behaviour 
therapy and social rhythms and has shown a beneficial 
effect after the 1-year follow-up in comparison to TAU 
[47]. Another included a combination of CBT plus psy-
choeducation and reported that it was more effective in 
comparison to TAU in 40 refractory BD patients concern-
ing hospitalization and residual symptoms at 12 months 
follow-up [27]. A collaborative care study on 138 patients 
and follow-up of 12 months also gave positive results 
[48]. One multicentred Italian study assessed the effi-
cacy of the Falloon model of psychoeducational family 
intervention (PFI), originally developed for schizophrenia 
management and adapted to BD-I disorder. It included 
137 recruited families, of which 70 were allocated to the 
experimental group and 67 to the TAU group. At the end 
of the intervention, significant improvements in patients’ 
social functioning and relatives’ burden were found in the 
treated group compared to TAU [49]. In general, the ben-
eficial effect seems to be present concerning manic but 
not depressive episodes [50, 51], while a benefit on social 
role function and quality of life seems also to be present 
[50].
The comparison of 12 sessions of psychoeducation 
vs. TAU in 71 BD patients reported that at 6 weeks, the 
intervention improved treatment adherence [52], while 
another on 61 BD-II patients reported no significant 
effect on the regulation of biological rhythms when com-
pared to standard pharmacological treatment [53]. No 
significant effect was reported concerning the quality of 
life by another recent study on 61 young bipolar adults 
[54]. On the contrary, a trial on 47 BD patients reported 
that a psychoeducation programme designed for inter-
nalized stigmatization may have positive effects on the 
internalized stigmatization levels of patients with bipolar 
disorder [55].
There is preliminary evidence that a Web-based treat-
ment approach in BD (‘Living with Bipolar’—LWB inter-
vention) is feasible and potentially effective [56]; however, 
other Web-based attempts returned negative results [57]. 
Automated mobile-phone intervention is another option 
and it has been reported to be feasible, acceptable and 
might enhance the impact of brief psychoeducation on 
depressive symptoms in BD. However, sustainment of 
gains from symptom self-management mobile interven-
tions, once stopped, may be limited [58].
One meta-analysis of 16 studies, 8 of which provided 
data on relapse reported that psychoeducation appeared 
to be effective in preventing any relapse (OR: 1.98–
2.75; NNT: 5–7) and manic/hypomanic relapse (OR: 
1.68–2.52; NNT: 6–8), but not depressive relapse. That 
meta-analysis reported that group, but not individually, 
delivered interventions were effective against both poles 
of relapse [59].
In summary, the literature suggests that interven-
tions of 6-month group psychoeducation seem to exert 
a long-lasting prophylactic effect. However this is rather 
restricted to manic episodes and to patients at the ear-
lier stages of the disease who have achieved remission 
before the intervention has started. Although the mecha-
nism of action of psychoeducation remains unknown, it 
is highly likely that the beneficial effect is mediated by the 
enhancement of treatment adherence, the promoting of 
lifestyle regularity and healthy habits and the teaching of 
early detection of prodromal signs.
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Interpersonal and social rhythm therapy (IPSRT)
Interpersonal and social rhythm therapy is based on the 
hypothesis that in vulnerable individuals, the experi-
ence of stressful life events and unstable or disrupted 
daily routines can lead to affective episodes via circadian 
rhythm instability [18]. In this frame, IPSRT includes the 
management of affective symptoms through improve-
ment of adherence to medication and stabilizing social 
rhythms and the resolution of interpersonal problems. 
Four papers investigating its efficacy were identified.
The first study concerning its efficacy in BD included 
175 acutely ill BD patients and followed them for 2 years. 
It included four treatment groups, reflecting IPSRT vs. 
intensive clinical management during the acute and the 
maintenance phase. The results revealed no difference 
between interventions in terms of time to remission and 
in the proportion of patients achieving remission (70 vs. 
72%), although those patients who received IPSRT dur-
ing the acute treatment phase survived longer without an 
episode and showed higher regularity of social rhythms 
[60]. In spite of some encouraging findings from post hoc 
analysis, there were eventually no significant differences 
between genders and concerning the improvement in 
occupational functioning [61]. More recently, a 12-week 
study in which unmedicated depressed BD-II patients 
were randomized to IPSRT (N = 14) vs. treatment with 
quetiapine (up to 300 mg/day; N = 11), showed that both 
groups experienced significant reduction in symptoms 
over time, but there were no group-by-time interactions. 
Response and drop-out rates were similar [62]. Finally, 
one 78-week trial investigated the efficacy of IPSRT vs. 
specialist supportive care on depressive and mania out-
comes and social functioning, and mania outcomes in 
100 young BD patients. The results revealed no signifi-
cant difference between therapies [63].
Overall, there are no convincing data on the usefulness 
of IPSRT during the maintenance phase of BD. There are, 
however, some data suggesting that if applied early and 
particularly already during the acute phase, it might pro-
long the time to relapse.
Family intervention
The standard family intervention for BD targets the 
whole family and not only the patient and includes ele-
ments of psychoeducation, communication enhancement 
and problem-solving skills training. It also includes sup-
port and self-care training for caregivers. Fifteen papers 
concerning the efficacy of family intervention in BD were 
found.
The first study on this intervention took part in 1991 
and reported that carer-focused interventions improve 
the knowledge of the illness [64]. Since then, there have 
been a number of studies which in general support the 
use of adjunctive family-focused treatment. There are 
different designs and approaches which were tested in 
essentially open trials.
One intervention design consists of 21 1-h sessions 
which combine psychoeducation, communication skills 
training and problem-solving training. The sessions take 
place at home and included both the patient and his/her 
family during the post-episode period. The treatment 
has shown its efficacy vs. crisis management in 101 BD 
patients in reducing relapses (35 vs. 54%) and increas-
ing time to relapse (53 vs. 73  weeks, respectively) [65, 
66]. It was also reported to reduce hospitalization risk 
compared with individual treatment (12 vs. 60%) [67]. 
It is important that the benefits extended to the 2-year 
follow-up were particularly useful for depressive symp-
toms, in families with high expressed emotion and for 
the improvement of medication adherence [66]. Similar 
results were reported by a study of 81 BD patients and 
33 family dyads, which reported that the odds ratio for 
hospitalization at 1-year follow-up was related with high 
perceived criticism (by the patients from their relatives), 
poor adherence and with the relatives’ lack of knowledge 
concerning BD (OR: 3.3; 95% CI 1.3–8.6) [68].
Adjunctive psychoeducational marital intervention in 
acutely ill patients was reported to have a beneficial effect 
concerning medication adherence and global function-
ing, but not for symptoms [69]. Neither adjunctive fam-
ily therapy nor adjunctive multifamily group therapy 
improves the recovery rate from acute bipolar episodes 
when compared with pharmacotherapy alone [14]. These 
interventions could be beneficial for patients from fami-
lies with high levels of impairment and could result in a 
reduction of both the number of depressive episodes and 
the time spent in depression (Cohen d =  0.7–1.0) [70]. 
In this frame, in those patients who recovered from the 
intake episode, multifamily group therapy was associated 
with the lowest hospitalization risk [71].
Another format included a 90-min duration, delivered 
to caregivers of euthymic BD patients; after 15-months, 
it was reported to have both reduced the risk of recur-
rence in comparison to a control group (42 vs. 66%; 
NNT: 4.1 with 95% CI 2.4–19.1) and also to have delayed 
recurrence [72]. It was particularly efficacious in the pre-
vention of hypomanic/manic episodes and also in the 
reduction of the overall family burden [73]. It had been 
shown before that carer-focused interventions improve 
the knowledge of the illness [64], reduce burden [74] and 
also reduce the general and mental health risk of caregiv-
ers [75].
Another format of intervention included 12 sessions of 
group psychoeducation for the patients and their fami-
lies. It has been found superior to TAU in 58 BD patients 
concerning the prevention of relapses, the decrease of 
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manic symptoms and the improvement of medication 
adherence [76]. Finally, the comparison of family-based 
therapy (FBT) vs. brief psychoeducation (crisis manage-
ment) in 108 patients with BD reported that the outcome 
depended on the existing levels of appropriate self-sacri-
fice [77].
Overall, the literature supports the conclusion that 
interventions which focus on families and caregivers 
exert a beneficial impact on family members, but the 
effect on the patients themselves is controversial. The 
effect includes issues ranging from subjective well-being 
to general health, but it is almost certain that there is a 
beneficial effect on issues like treatment adherence.
Intensive psychosocial intervention
There are three papers investigating various methods 
of intensive psychosocial intervention. ‘Intensive’ psy-
chotherapy has been tested on 293 acutely depressive 
BD outpatients in a multi-site study. Patients were ran-
domized to 3 sessions of psychoeducation vs. up to 30 
sessions of intensive psychotherapy (family-focused 
therapy, IPSRT or CBT). The results suggested that the 
intensive psychotherapy group showed higher recov-
ery rates, shorter times to recovery and greater likeli-
hood of being clinically well in comparison to patients 
on short intervention [78]. The functional outcome was 
also reported to be better after 1 year [79]. A second trial 
randomized 138 BD patients to receive collaborative 
care (contracting, psychoeducation, problem-solving 
treatment, systematic relapse prevention and monitor-
ing of outcomes) vs. TAU. The results suggested that col-
laborative care had a significant and clinically relevant 
effect on the number of months with depressive symp-
toms, as well as on severity of depressive symptoms, but 
there was no effect on symptoms of mania or on treat-
ment adherence [48].
Cognitive remediation (CR) and functional remediation 
(FR)
Cognitive remediation and functional remediation tai-
lored to the needs of BD patients include education on 
neurocognitive deficits, communication, autonomy and 
stress management. There are five papers on the efficacy 
of CR and FR.
One uncontrolled study in 15 BD patients applied a 
type of CR and focused on mood monitoring and resid-
ual depressive symptoms, organization, planning and 
time management, attention and memory. The results 
suggested that there was an improvement of residual 
depressive symptoms, executive functions and gen-
eral functioning. Patients with greater neurocognitive 
impairment had less benefit from the intervention [80]. 
The combination of neurocognitive techniques with 
psychoeducation and problem solving within an eco-
logical framework was tested in a multicentre trial in 239 
euthymic BD patients with a moderate–severe degree 
of functional impairment (N =  77) vs. psychoeducation 
(N = 82) and vs. TAU (N = 80). At end point, the com-
bined programme was superior to TAU, but not to psy-
choeducation alone [81, 82]. Finally, a small study in 37 
BD and schizoaffective patients tested social cognition 
and interaction training (SCIT) as adjunctive to TAU 
(N =  21) vs. TAU alone (N =  16). There was no differ-
ence between groups concerning social functioning, but 
there was a superiority of the combination group in the 
improvement of emotion perception, theory of mind, 
hostile attribution bias and depressive symptoms [83]. 
A post hoc analysis using data of 53 BD-II outpatients 
compared FR vs. psychoeducation and vs. TAU, but the 
results were negative [84].
Mindfulness‑based interventions
Mindfulness-based intervention aims to enhance the 
ability to keep one’s attention on purpose in the pre-
sent moment and non-judgmentally. Specifically for 
BD patients, it includes education about the illness and 
relapse-prevention, combination of cognitive therapy 
and training in mindfulness meditation to increase the 
awareness of the patterns of thoughts, feelings and bodily 
sensations and the development of a different way (non-
judgementally) of relating to thoughts, feelings and bod-
ily sensations. It also promotes the ability of the patients 
to choose the most skilful response to thoughts, feelings 
or situations. There are eight studies on the efficacy of 
mindfulness-based intervention in BD.
The first study concerning the application of mindful-
ness-based cognitive therapy (MBCT) in BD tested it 
vs. waiting list and included only eight patients in each 
group. The results suggested a beneficial effect with a 
reduction in anxiety and depressive symptoms [85]. A 
second study included 23 BD patients and 10 healthy 
controls and investigated MBCT vs. waiting list and the 
results were compared with those of 10 healthy controls. 
The results suggested that following MBCT, there were 
significant improvements in BD patients concerning 
mindfulness, anxiety and emotion regulation, working 
memory, spatial memory and verbal fluency compared 
to the waiting list group [86]. The biggest study so far 
concerning MBCT included 95 BD patients and tested 
MBCT as adjunctive to TAU (N  =  48) vs. TAU alone 
(N =  47) and followed the patients for 12  months. The 
results showed no difference between treatment groups 
in terms of relapse and recurrent rates of any mood epi-
sodes. There was some beneficial effect of MBCT on anx-
iety symptoms [87, 88]. Recently, the focus has expanded 
to analyze the impact of MBCT on brain activity and 
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cognitive functioning in BD, but the findings are difficult 
to interpret [86, 89, 90].
A study which applied dialectical behaviour therapy 
in which mindfulness represented a large component 
also reported some positive outcomes [91]. One study 
on mindfulness training reported negative results in BD 
patients [92].
In conclusion, the literature does not support a benefi-
cial effect of MBCT on the core issues of BD. There are 
some data suggesting a beneficial effect on anxiety in BD 
patients. So far, there are no data supporting its efficacy 
in the prevention of recurrences.
Discussion
The current review suggests that the literature supports 
the usefulness only of psychoeducation for the relapse 
prevention of mood episodes and unfortunately only in a 
selected subgroup of patients at an early stage of the dis-
ease who have very good if not complete remission of the 
acute episode. On the other hand, CBT and IPSRT could 
have some beneficial effect during the acute phase, but 
more data are needed. Mindfulness interventions could 
only decrease anxiety, while interventions to improve 
neurocognition seem to be rather ineffective. Family 
intervention seems to have benefits mainly for caregivers, 
but it is uncertain whether they have an effect on patient 
outcomes. A summary of the specific areas of efficacy for 
each of the above-mentioned interventions is shown in 
Table 1.
An additional important conclusion is that concern-
ing the quality of the data available: the studies on BD 
patients suffer from the same limitations and methodo-
logical problems as all psychotherapy trials do. It is well 
known that this kind of studies suffers from problems 
pertaining to blindness and the nature of the control 
intervention. Additionally, the training of the therapist 
and the setting itself might play an important role. It is 
quite different to apply the same intervention in spe-
cialized centres than in real-world settings in everyday 
clinical practice. Even worse, research is not done in a 
standardized way and the gathering of data is far from 
systematic. The studies are rarely registered, adverse 
events are not routinely assessed, outcomes are not hier-
archically stated a priori and too many post hoc analyses 
have been published without being stated as such. There 
is a lack of replication of the same treatment by different 
research groups under the same conditions.
There are different theories on the mechanisms respon-
sible for the efficacy of the psychosocial treatments. 
One suggestion concerns the enhancement of treatment 
adherence [93], while another proposes that improving 
lifestyle and especially biological rhythms, food intake 
and social zeitgebers could be the key factors [60]. Also, 
it has been proposed that the mechanism concerns the 
changing of dysfunctional attitudes [23], the improve-
ment of family interactions [94] or the enhanced ability 
for the early identification of signs of relapse [35].
Overall, it seems that psychosocial interventions are 
more efficacious when applied on patients who are at an 
early stage of the disease and who were euthymic when 
recruited [14, 95]. According to these post hoc analyses, 
a higher number of previous episodes [13, 40] as well as 
a higher psychiatric morbidity and more severe func-
tional impairment [96] might reduce treatment response, 
although the data are not conclusive [97]. Also, a dif-
ferential effect has been proposed with neuroprotective 
strategies being better during the early stages [98] and 
rehabilitative interventions being preferable at later 
stages [99].
It is unclear whether IPSRT and CBT are efficacious 
during the acute episodes, but there are some data in 
support [13, 60, 78]. Maybe specific family environment 
Table 1 Specific psychosocial interventions and their targeted therapeutic effect in BD
Eq equivocal.
Intervention Efficacy




Anxiety neurocognition Overall 
functioning
CBT No – Yes – – –
Psychoeducation Yes No No – – Yes
IPSRT Eq Eq Eq – – –
Family intervention No No No – – No
Intensive psychosocial  
intervention
– – – – – –
Cognitive remediation No No No – No No
Mindfulness-based  
interventions
No No No Yes – –
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characteristics might influence the response to treatment 
[70, 100]. Probably, there were subpopulations who espe-
cially benefited from these treatments [13, 70], but these 
assumptions are based on post hoc analyses alone.
It should be mentioned that most of the research con-
cerns pure and classic BD-I patients, although there are 
some rare data concerning special populations such 
as BD-II [36, 62], schizoaffective disorder [101, 102], 
patients with high suicide risk [85, 103, 104] and patients 
with comorbid substance abuse [105, 106].
It is interesting to note that the literature suggests that 
the benefits of psychosocial interventions if achieved 
could last for up to 5  years [36, 107], although some 
patients might need booster sessions [23, 108]. The com-
plete range of the effect these interventions have is still 
uncharted. Although it is reasonable to expect a benefi-
cial effect in a number of problems, including suicidality, 
research data on these issues are virtually non-existent 
[103, 104].
Conclusions
In conclusion, the literature supports the notion that 
adjunctive specific psychological treatments can 
improve specific illness outcomes. Although the data 
are rare, it seems reasonable that any such intervention 
should be applied as early as possible and should always 
be tailored to the specific needs of the patient in the 
context of personalized patient care, since it is accepted 
that both the patients and their relatives have differ-
ent needs and problems depending on the stage of the 
illness.
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